Single Genomic Test Aims to Accelerate Diagnoses for Rare Genetic Diseases
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children.
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children.
Sherlock Bio is making its proprietary AI platform freely available to anyone interested in developing diagnostics assays.
The QIAstat-Dx Analyzer 2.0 enables mobile access to test results, streamlining diagnostic processes and enhancing patient care.
The Mohawk 48 uses forty-eight solenoid pins to enable a specific frozen or thawed sample tube to be raised and selected.
This blood test could help physicians establish that Alzheimer’s disease is likely not the cause of patients’ mild cognitive impairment.